|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/21 | |
| A61K 47/48 | |||
| A61P 35/00 |
| (11) | Number of the document | 1535623 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05002952.9 |
| Date of filing the European patent application | 2000-04-06 | |
| (97) | Date of publication of the European application | 2005-06-01 |
| (45) | Date of publication and mention of the grant of the patent | 2008-12-31 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 288359 | 1999-04-08 | US |
| (72) |
Rose, Esther Helen, US
Rybak, Mary Ellen, US
|
| (73) |
Schering Corporation,
2000 Galloping Hill Road, Kenilworth, NJ 07033,
US
|
| (54) | Renal cell carcinoma treatment |
| Renal cell carcinoma treatment |